Develops dielectric-spectroscopy cell analysis (CDS) for bioprocessing and cell therapies.
| Date | Round | Amount |
|---|---|---|
| Aug 2023 | Funding round Edinburgh-based life-science firm Cytomos raised GBP4M led by Archangels to scale its cell-analysis technology. | $4.6M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.